Lopes C - Search Results

1

Value of the Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma.

Santos M, Correia-Gomes C, Marcos R, Santos A, De Matos A, Lopes C, Dias-Pereira P. Santos M, et al. Among authors: lopes c. Anticancer Res. 2015 Jul;35(7):4219-27. Anticancer Res. 2015. PMID: 26124382

2

Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance.

Queiroga FL, Perez-Alenza MD, Silvan G, Peña L, Lopes C, Illera JC. Queiroga FL, et al. Among authors: lopes c. Anticancer Res. 2005 Nov-Dec;25(6B):4269-75. Anticancer Res. 2005. PMID: 16309227 Free article.

3

Decrease of E-cadherin expression in canine cutaneous histiocytoma appears to be related to its spontaneous regression.

Pires I, Queiroga FL, Alves A, Silva F, Lopes C. Pires I, et al. Among authors: lopes c. Anticancer Res. 2009 Jul;29(7):2713-7. Anticancer Res. 2009. PMID: 19596951 Free article.

4

Regression of canine cutaneous histiocytoma: reduced proliferation or increased apoptosis?

Pires I, Alves A, Queiroga FL, Silva F, Lopes C. Pires I, et al. Among authors: lopes c. Anticancer Res. 2013 Apr;33(4):1397-400. Anticancer Res. 2013. PMID: 23564778

5

Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.

DA Cruz Paula A, Marques O, Rosa AM, DE Fátima Faria M, Rêma A, Lopes C. DA Cruz Paula A, et al. Among authors: lopes c. Anticancer Res. 2014 Mar;34(3):1427-34. Anticancer Res. 2014. PMID: 24596390

6

Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.

Santos M, Correia-Gomes C, Santos A, de Matos A, Rocha E, Lopes C, Pereira PD. Santos M, et al. Among authors: lopes c. Vet J. 2014 Jun;200(3):426-33. doi: 10.1016/j.tvjl.2014.03.019. Epub 2014 Mar 28. Vet J. 2014. PMID: 24745769

7

The N-nitrosodiethylamine mouse model: sketching a timeline of evolution of chemically-induced hepatic lesions.

Da Costa RM, Paula-Santos N, Rocha AF, Colaço A, Lopes C, Oliveira PA. Da Costa RM, et al. Among authors: lopes c. Anticancer Res. 2014 Dec;34(12):7029-37. Anticancer Res. 2014. PMID: 25503129

8

Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.

DA Cruz Paula A, Marques O, Sampaio R, Rosa A, Garcia J, Rêma A, DE Fátima Faria M, Silva P, Vizcaíno R, Lopes C. DA Cruz Paula A, et al. Among authors: lopes c. Anticancer Res. 2016 Sep;36(9):4629-38. doi: 10.21873/anticanres.11013. Anticancer Res. 2016. PMID: 27630305

9

Prognostic and Therapeutic Potential Implications of Genetic Variability in Prostaglandin E2 Pathway Genes in Rectal Cancer.

Santos MD, Silva C, Rocha A, Nogueira C, Castro-Poças F, Araujo A, Matos E, Pereira C, Medeiros R, Lopes C. Santos MD, et al. Among authors: lopes c. Anticancer Res. 2017 Jan;37(1):281-291. doi: 10.21873/anticanres.11319. Anticancer Res. 2017. PMID: 28011504

10

Malignant canine mammary tumours: Preliminary genomic insights using oligonucleotide array comparative genomic hybridisation analysis.

Santos M, Dias-Pereira P, Williams C, Lopes C, Breen M. Santos M, et al. Among authors: lopes c. Vet J. 2017 Apr;222:68-71. doi: 10.1016/j.tvjl.2017.03.005. Epub 2017 Mar 28. Vet J. 2017. PMID: 28392153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,264 results

Search Page

Filters